​
​

Pieris Pharmaceuticals Ownership | Who Owns Pieris Pharmaceuticals?

OverviewRevenueFinancialsChart

Pieris Pharmaceuticals Ownership Summary

Pieris Pharmaceuticals is owned by 38.15% institutional investors, and 61.85% retail investors. Geode capital management is the largest institutional shareholder, holding 0% of PIRS shares. Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund, with 0.84% of its assets in Pieris Pharmaceuticals shares.

PIRS Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockPieris Pharmaceuticals38.15%-61.85%
SectorHealthcare Stocks 47.06%8.01%44.93%
IndustryBiotech Stocks 44.97%7.82%47.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Geode capital management---
Cerity partners---
Prudential financial---
Renaissance---
Blackrock---
Two sigma advisers, lp---
Tower research capital llc (trc)---
Two sigma securities---
Bvf inc/il---
Commerce bank---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Geode capital management---
Cerity partners---
Prudential financial---
Renaissance---
Blackrock---
Two sigma advisers, lp---
Tower research capital llc (trc)---
Two sigma securities---
Bvf inc/il---
Commerce bank---

Top Buyers

HolderShares% AssetsChange
Allworth financial lp---350.00
Advisor group---516.00
Truvestments capital---1.12K
Jpmorgan chase---1.99K
Barclays---5.01K

Top Sellers

HolderShares% AssetsChange
Bvf inc/il---20.61M
Lynx1 capital management lp---8.78M
Renaissance---1.43M
Blackrock---1.04M
Citadel advisors---967.24K

Sold Out

HolderChange
Allworth financial lp-350.00
Advisor group-516.00
Truvestments capital-1.12K
Jpmorgan chase-1.99K
Barclays-5.01K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202440-13.04%37,747,023-2.00%382.51%1515.38%6-33.33%
Dec 31, 2023464.55%38,517,239-4.57%381.84%13-27.78%9125.00%
Sep 30, 202344-8.33%40,359,937-16.98%461.08%1838.46%4-76.47%
Jun 30, 202348-22.58%48,613,34441.95%653.09%13-31.58%17-10.53%
Mar 31, 202362-3.13%34,247,524-3.28%452.02%19-9.52%19-13.64%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Institutional Extnd Mkt Idx Tr11.07K0.84%-
Fidelity Extended Market Index7.32K0.55%-1.11K
Gestión Boutique VIII Global Gradient3.67K0.28%3.67K
NT Ext Equity Mkt Idx Fd - NL2.07K0.16%-
Fidelity Series Total Market Index1.71K0.13%621.00
NT Ext Equity Mkt Idx Fd - DC - NL - T21.67K0.13%5.00
BlackRock Extended Equity Market K1.41K0.11%-1.00
Fidelity Total Market Index1.26K0.10%-
Spartan Extended Market Index Pool E917.000.07%917.00
Northern Trust Extended Eq Market Idx884.000.07%-

Recent Insider Transactions

DateNameRoleActivityValue
Aug 07, 2024GERAGHTY JAMES A-Buy$1.00
Aug 12, 2024ADAR1 Capital Management, LLC-Buy$12.02K
Aug 09, 2024ADAR1 Capital Management, LLC-Buy$44.68K
Aug 12, 2024ADAR1 Capital Management, LLC-Buy$35.62K
May 25, 2023KIRITSY CHRISTOPHER P-Buy$8.50K

Insider Transactions Trends

DateBuySell
2024 Q33-
2023 Q21-
2023 Q1--
2022 Q21-
2022 Q1--

PIRS Ownership FAQ

Who Owns Pieris Pharmaceuticals?

Pieris Pharmaceuticals shareholders are primarily institutional investors at 38.15%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Pieris Pharmaceuticals's industry, Biotech Stocks , is 44.97%, which Pieris Pharmaceuticals falls below.

Who owns the most shares of Pieris Pharmaceuticals?

Pieris Pharmaceuticals’s largest shareholders are Geode capital management (0 shares, 0%), Cerity partners (0 shares, 0%), and Prudential financial (0 shares, 0%). Together, they hold 0% of Pieris Pharmaceuticals’s total shares outstanding.

Does Blackrock own Pieris Pharmaceuticals?

Yes, BlackRock owns 0% of Pieris Pharmaceuticals, totaling 0 shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 0$. In the last quarter, BlackRock decreased its holdings by -1.038M shares, a -100.00% change.

Who is Pieris Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Geode capital management is Pieris Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 Pieris Pharmaceuticals shares, valued at 0$.

Who is the top mutual fund holder of Pieris Pharmaceuticals shares?

Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund holder of Pieris Pharmaceuticals shares, with 0.84% of its total shares outstanding invested in 11.07K Pieris Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools